Biogen’s Vumerity Patent Suit Against Zydus Whittled to Validity – Bloomberg Law News

IP Law. A pedestrian walks past Biogen Inc. headquarters in Cambridge … Zydus’ generic diroximel fumarate, Vumerity’s active ingredient, infringes …